Recent Advances in Diagnosing Chronic Pulmonary Aspergillosis

Purpose: The diagnosis of chronic pulmonary aspergillosis (CPA) is occasionally complicated due to poor sensitivity of mycological culture and colonization of Aspergillus species in the airway. Several diagnostic methods have been developed for the diagnosis of invasive pulmonary aspergillosis; howe...

Full description

Bibliographic Details
Main Authors: Takahiro Takazono, Koichi Izumikawa
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-08-01
Series:Frontiers in Microbiology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fmicb.2018.01810/full
_version_ 1818541442182676480
author Takahiro Takazono
Takahiro Takazono
Koichi Izumikawa
author_facet Takahiro Takazono
Takahiro Takazono
Koichi Izumikawa
author_sort Takahiro Takazono
collection DOAJ
description Purpose: The diagnosis of chronic pulmonary aspergillosis (CPA) is occasionally complicated due to poor sensitivity of mycological culture and colonization of Aspergillus species in the airway. Several diagnostic methods have been developed for the diagnosis of invasive pulmonary aspergillosis; however, their interpretation and significance are different in CPA. This study aimed to review the recent advances in diagnostic methods and their characteristics in the diagnosis of CPA.Recent findings: Radiological findings of lung, histopathology, and culture are the gold standard of CPA diagnosis. Serodiagnosis methods involving the use of galactomannan and β-D-glucan have low sensitivity and specificity. An Aspergillus-specific IgG antibody assay showed good performance and had better sensitivity and reproducibility than conventional precipitant antibody assays. Currently, it is the most reliable method for diagnosing CPA caused by Aspergillus fumigatus, but evidence on its effectiveness in diagnosing CPA caused by non-fumigatus Aspergillus is lacking. Newly developed lateral flow device Aspergillus and detection of volatile organic compounds in breath have potential, but evidence on its effectiveness in diagnosing CPA is lacking. The increasing prevalence of azole-resistant A. fumigatus strains has become a threat to public health. Some of the azole-resistant-related genes can be detected directly from clinical samples using a commercially available kit. However, its clinical efficacy for routine use remains unclear, since resistance-related genes greatly differ among regions and countries.Conclusion: Several issues surrounding the diagnosis of CPA remain unclear. Hence, further investigations and clinical studies are needed to improve the accuracy and efficiency of CPA diagnosis.
first_indexed 2024-12-11T22:09:20Z
format Article
id doaj.art-12ab15fa9f574c929bdbfdb94a267b5c
institution Directory Open Access Journal
issn 1664-302X
language English
last_indexed 2024-12-11T22:09:20Z
publishDate 2018-08-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Microbiology
spelling doaj.art-12ab15fa9f574c929bdbfdb94a267b5c2022-12-22T00:48:51ZengFrontiers Media S.A.Frontiers in Microbiology1664-302X2018-08-01910.3389/fmicb.2018.01810388550Recent Advances in Diagnosing Chronic Pulmonary AspergillosisTakahiro Takazono0Takahiro Takazono1Koichi Izumikawa2Department of Infectious Diseases, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, JapanSecond Department of Internal Medicine, Nagasaki University Hospital, Nagasaki, JapanDepartment of Infectious Diseases, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, JapanPurpose: The diagnosis of chronic pulmonary aspergillosis (CPA) is occasionally complicated due to poor sensitivity of mycological culture and colonization of Aspergillus species in the airway. Several diagnostic methods have been developed for the diagnosis of invasive pulmonary aspergillosis; however, their interpretation and significance are different in CPA. This study aimed to review the recent advances in diagnostic methods and their characteristics in the diagnosis of CPA.Recent findings: Radiological findings of lung, histopathology, and culture are the gold standard of CPA diagnosis. Serodiagnosis methods involving the use of galactomannan and β-D-glucan have low sensitivity and specificity. An Aspergillus-specific IgG antibody assay showed good performance and had better sensitivity and reproducibility than conventional precipitant antibody assays. Currently, it is the most reliable method for diagnosing CPA caused by Aspergillus fumigatus, but evidence on its effectiveness in diagnosing CPA caused by non-fumigatus Aspergillus is lacking. Newly developed lateral flow device Aspergillus and detection of volatile organic compounds in breath have potential, but evidence on its effectiveness in diagnosing CPA is lacking. The increasing prevalence of azole-resistant A. fumigatus strains has become a threat to public health. Some of the azole-resistant-related genes can be detected directly from clinical samples using a commercially available kit. However, its clinical efficacy for routine use remains unclear, since resistance-related genes greatly differ among regions and countries.Conclusion: Several issues surrounding the diagnosis of CPA remain unclear. Hence, further investigations and clinical studies are needed to improve the accuracy and efficiency of CPA diagnosis.https://www.frontiersin.org/article/10.3389/fmicb.2018.01810/fullaspergillosisAspergillusgalactomannanAspergillus IgG antibodyazole resistance
spellingShingle Takahiro Takazono
Takahiro Takazono
Koichi Izumikawa
Recent Advances in Diagnosing Chronic Pulmonary Aspergillosis
Frontiers in Microbiology
aspergillosis
Aspergillus
galactomannan
Aspergillus IgG antibody
azole resistance
title Recent Advances in Diagnosing Chronic Pulmonary Aspergillosis
title_full Recent Advances in Diagnosing Chronic Pulmonary Aspergillosis
title_fullStr Recent Advances in Diagnosing Chronic Pulmonary Aspergillosis
title_full_unstemmed Recent Advances in Diagnosing Chronic Pulmonary Aspergillosis
title_short Recent Advances in Diagnosing Chronic Pulmonary Aspergillosis
title_sort recent advances in diagnosing chronic pulmonary aspergillosis
topic aspergillosis
Aspergillus
galactomannan
Aspergillus IgG antibody
azole resistance
url https://www.frontiersin.org/article/10.3389/fmicb.2018.01810/full
work_keys_str_mv AT takahirotakazono recentadvancesindiagnosingchronicpulmonaryaspergillosis
AT takahirotakazono recentadvancesindiagnosingchronicpulmonaryaspergillosis
AT koichiizumikawa recentadvancesindiagnosingchronicpulmonaryaspergillosis